Company intelligence / Profile preview

AbCheck

Plzeň, Plzensky, Czech Republicabcheckantibodies.com ↗

Ownership: Private
Employees: ~29
Development stage: Preclinical

Overview

AbCheck is an antibody discovery and optimization specialist with over 15 years of experience. It has delivered multiple clinical candidates through more than 45 partnerships but does not have its own pipeline of marketed or late-stage drugs. Its technologies are validated by industry collaborations across the US and Europe.

Modalities: AntibodyMonoclonal antibodyHumanized single-chain antibody fragment
Industry: Drug Discovery Services

Partnerships

Over 45 biopharma partnerships globally (specific companies not disclosed)Partnerships with companies in the Flagship Pioneering ecosystem post-acquisition

Beyond the preview

Go deeper on AbCheck.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AbCheck.

Explore the full profile